Leerink Partners Remains Bullish as Fate Therapeutics (FATE) Plans to Initiate ProTmune Study
Go back to Leerink Partners Remains Bullish as Fate Therapeutics (FATE) Plans to Initiate ProTmune Study| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.16 | 52 Week High | $4.76 | |||
| Open | $2.16 | 52 Week Low | $1.46 | |||
| Day High | $2.16 | P/E | N/A | |||
| Day Low | $2.16 | EPS | $-1.91 | |||
| Volume | 212,979 | |||||
